All Stories

  1. Astrocytic Alterations and Dysfunction in Down Syndrome: Focus on Neurogenesis, Synaptogenesis, and Neural Circuits Formation
  2. ER-mitochondria distance is a critical parameter for efficient mitochondrial Ca2+ uptake and oxidative metabolism
  3. The Bioactive Gamma-Oryzanol from Oryza sativa L. Promotes Neuronal Differentiation in Different In Vitro and In Vivo Models
  4. Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease
  5. Neural stem cell-derived extracellular vesicles: mini players with key roles in neurogenesis, immunomodulation, neuroprotection and aging
  6. Heterogenous response to aging of astrocytes in murine Substantia Nigra pars compacta and pars reticulata
  7. Protein synthesis inhibition and loss of homeostatic functions in astrocytes from an Alzheimer’s disease mouse model: a role for ER-mitochondria interaction
  8. Complex and regional-specific changes in the morphological complexity of GFAP+ astrocytes in middle-aged mice
  9. β2 and α2 adrenergic receptors mediate the proneurogenic in vitro effects of norquetiapine
  10. Extracellular Vesicles, Influential Players of Intercellular Communication within Adult Neurogenic Niches
  11. Proteomic analysis links alterations of bioenergetics, mitochondria-ER interactions and proteostasis in hippocampal astrocytes from 3xTg-AD mice
  12. Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome
  13. Correction: Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer’s disease mouse model
  14. Activation of β2 adrenergic receptors promotes adult hippocampal neurogenesis
  15. Astrocyte-Derived Paracrine Signals: Relevance for Neurogenic Niche Regulation and Blood–Brain Barrier Integrity
  16. Deletion of calcineurin from GFAP‐expressing astrocytes impairs excitability of cerebellar and hippocampal neurons through astroglial Na + /K + ATPase
  17. Salmeterol, a β2 Adrenergic Agonist, Promotes Adult Hippocampal Neurogenesis in a Region-Specific Manner
  18. Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome
  19. Tapentadol: an effective option for the treatment of back pain [Corrigendum]
  20. Pharmacological rationale for tapentadol therapy: a review of new evidence
  21. Tapentadol: an effective option for the treatment of back pain
  22. Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer’s disease mouse model
  23. Advances in stem cell therapy for amyotrophic lateral sclerosis
  24. Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling
  25. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome
  26. Melanocortin 4 receptor stimulation improves social deficits in mice through oxytocin pathway
  27. Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis
  28. TGF-β2 and TGF-β3 from cultured β-amyloid-treated or 3xTg-AD-derived astrocytes may mediate astrocyte-neuron communication
  29. l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug
  30. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS
  31. Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies
  32. Proneurogenic Effects of Trazodone in Murine and Human Neural Progenitor Cells
  33. Opiate Analgesics as Negative Modulators of Adult Hippocampal Neurogenesis: Potential Implications in Clinical Practice
  34. Novel insights into the role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells
  35. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?
  36. Cell autonomous and noncell-autonomous role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells
  37. New insights on trazodone effect in promoting neuronal differentiation of adult murine hippocampal neural progenitor cells
  38. Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice
  39. Not only a bad guy: potential proneurogenic role of the RAGE/NF-κB axis in Alzheimer's disease brain
  40. Dopamine Receptor Agonists for Protection and Repair in Parkinson's Disease: An Update
  41. Early growth response 2 (Egr-2) expression is triggered by NF-κB activation
  42. The MMP-1/PAR-1 Axis Enhances Proliferation and Neuronal Differentiation of Adult Hippocampal Neural Progenitor Cells
  43. Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling
  44. The Noradrenergic Component in Tapentadol Action Counteracts μ-Opioid Receptor–Mediated Adverse Effects on Adult Neurogenesis
  45. NF-κB Mediated Regulation of Adult Hippocampal Neurogenesis: Relevance to Mood Disorders and Antidepressant Activity
  46. Upregulation of mGlu2 Receptors via NF-κB p65 Acetylation Is Involved in the Proneurogenic and Antidepressant Effects of Acetyl-L-Carnitine
  47. High-Mobility Group Box-1 Protein and  -Amyloid Oligomers Promote Neuronal Differentiation of Adult Hippocampal Neural Progenitors via Receptor for Advanced Glycation End Products/Nuclear Factor- B Axis: Relevance for Alzheimer's Disease
  48. Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain
  49. α2δ Ligands Act as Positive Modulators of Adult Hippocampal Neurogenesis and Prevent Depression-Like Behavior Induced by Chronic Restraint Stress
  50. NF-κB Proteins in Adult Neurogenesis: Relevance for Learning and Memory in Physiology and Pathology
  51. Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain
  52. F640 DISTINCT DIFFERENCES BETWEEN TAPENTADOL AND MORPHINE IN AN IN VITRO MODEL OF ADULT NEUROGENESIS
  53. Nuclear Factor  B-Dependent Neurite Remodeling Is Mediated by Notch Pathway
  54. A novel role for the Receptor for Advanced Glycation End-products in neural progenitor cells derived from adult SubVentricular Zone
  55. A-ring modifications on the triazafluorenone core structure and their mGluR1 antagonist properties
  56. Tricyclic thienopyridine–pyrimidones/thienopyrimidine–pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain
  57. Astroglial-NF-kB is a critical regulator of learning and memory and hippocampal neurogenesis in female mice
  58. Adult dorsal root ganglia sensory neurons express the early neuronal fate marker doublecortin
  59. Dopamine Receptor Agonists for Protection and Repair in Parkinsons Disease
  60. Impaired Adult Neurogenesis Associated with Short-Term Memory Defects in NF- B p50-Deficient Mice
  61. Ecdysone-Based System for Controlled Inducible Expression of Metabotropic Glutamate Receptor Subtypes 2, 5, and 8
  62. Erratum to “Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice” [Behav. Brain Res. 160 (2005) 344–355]
  63. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice
  64. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles
  65. Members of the NF-κB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain
  66. Long-lasting induction of Notch2 in the hippocampus of kainate-treated adult mice
  67. Long-lasting induction of Notch2 in the hippocampus of kainate-treated adult mice
  68. Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695
  69. Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically
  70. Induction of p53 in the glutamate-induced cell death program
  71. Contribution of NF-κB and p53 in the glutamate-induced apoptosis
  72. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage
  73. Nuclear factor-κB/Rel proteins
  74. Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway
  75. Induction of tumour‐suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids
  76. Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity?
  77. Regulation of Mouse Neuropeptide Y Y1 Receptor Gene Transcription: A Potential Role for Nuclear Factor-κB/Rel Proteins
  78. Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-kappa B Activation
  79. Interleukin-1β and Glutamate Activate the NF-κB/Rel Binding Site from the Regulatory Region of the Amyloid Precursor Protein Gene in Primary Neuronal Cultures
  80. Identification and Characterization of a κB/Rel Binding Site in the Regulatory Region of the Amyloid Precursor Protein Gene
  81. Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors
  82. Molecular mechanisms of glutamate-induced neurodegeneration
  83. Tumor necrosis factor α mediates a T cell receptor-independent induction of the gene regulatory factor NF-κB in T lymphocytes
  84. IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
  85. NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes
  86. Molecular mechanisms involved in transport and release of dopamine in primary cultures of mesencephalic neurons
  87. A Novel Nuclear Factor Binds to the NF-ΚB Motif in the Interleukin-2 Enhancer
  88. Characterization of [3H]Dopamine Uptake Sites and [3H]Cocaine Recognition Sites in Primary Cultures of Mesencephalic Neurons During In Vitro Development
  89. Evidence for the involvement of distinct voltage-sensitive calcium channels in the release of 3H-dopamine from primary cultures of mesencephalic neurons
  90. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus
  91. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex